Literature DB >> 21228389

Olfactomedin 2: expression in the eye and interaction with other olfactomedin domain-containing proteins.

Afia Sultana1, Naoki Nakaya, Vladimir V Senatorov, Stanislav I Tomarev.   

Abstract

PURPOSE: Olfactomedin 2 (OLFM2) belongs to the family of olfactomedin domain-containing proteins. Genetic data suggest its association with glaucoma in Japanese patients. However, its functions are still elusive. In this study, the properties of mammalian OLFM2 were investigated.
METHODS: Expression of the rat and mouse Olfm2 gene was studied by using real-time PCR and in situ hybridization. Substitutions were introduced into OLFM2 by mutagenesis in vitro. Intracellular localization of OLFM2 was studied by confocal microscopy after transient transfection in HEK293 cells. Interaction of OLFM2 with olfactomedin 1 (Olfm1), olfactomedin 3 (Olfm3), myocilin, and gliomedin was studied by using co-immunoprecipitation.
RESULTS: Two major human OLFM2 mRNAs encode secreted proteins with a length of 454 and 478 amino acids. OLFM2 is more closely related to OLFM1 and -3 than to any other family members. Olfm2 showed the most dynamic expression pattern compared with Olfm1 and -3 during mouse eye development and was expressed preferentially in the developing retinal ganglion cell layer. Among three OLFM2 substitutions tested (T86M, R144Q, and L420S), only L420S completely blocked secretion of the protein. OLFM2 interacted with Olfm1 and -3, but not with myocilin and gliomedin. Co-transfection of the L420S mutant with wild-type Olfm1 and -3 significantly inhibited secretion of Olfm1 and -3.
CONCLUSIONS: Highly conserved OLFM2 protein may play an important role in the course of retinal and eye development. Severe mutations in one of the closely related olfactomedin domain-containing proteins (Olfm1-3) may block the secretion and probably the activity of all three family members, leading to more pronounced diseases of the retina than the knockout of individual genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228389      PMCID: PMC3088551          DOI: 10.1167/iovs.10-6356

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

1.  Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma.

Authors:  M F Adam; A Belmouden; P Binisti; A P Brézin; F Valtot; A Béchetoille; J C Dascotte; B Copin; L Gomez; A Chaventré; J F Bach; H J Garchon
Journal:  Hum Mol Genet       Date:  1997-11       Impact factor: 6.150

2.  Olfactomedin: purification, characterization, and localization of a novel olfactory glycoprotein.

Authors:  D A Snyder; A M Rivers; H Yokoe; B P Menco; R R Anholt
Journal:  Biochemistry       Date:  1991-09-24       Impact factor: 3.162

3.  Four structurally distinct neuron-specific olfactomedin-related glycoproteins produced by differential promoter utilization and alternative mRNA splicing from a single gene.

Authors:  P E Danielson; S Forss-Petter; E L Battenberg; L deLecea; F E Bloom; J G Sutcliffe
Journal:  J Neurosci Res       Date:  1994-07-01       Impact factor: 4.164

4.  Differentially expressed olfactomedin-related glycoproteins (Pancortins) in the brain.

Authors:  T Nagano; A Nakamura; Y Mori; M Maeda; T Takami; S Shiosaka; H Takagi; M Sato
Journal:  Brain Res Mol Brain Res       Date:  1998-01

5.  Identification of a gene that causes primary open angle glaucoma.

Authors:  E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

6.  Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints.

Authors:  Dorota F Zielinska; Florian Gnad; Jacek R Wiśniewski; Matthias Mann
Journal:  Cell       Date:  2010-05-28       Impact factor: 41.582

7.  Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants.

Authors:  Stéphane Gobeil; Marc-André Rodrigue; Steve Moisan; Thai D Nguyen; Jon R Polansky; Jean Morissette; Vincent Raymond
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

8.  A conserved postsynaptic transmembrane protein affecting neuromuscular signaling in Caenorhabditis elegans.

Authors:  Paula M Loria; Jonathan Hodgkin; Oliver Hobert
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  Bioinformatic approaches for identification and characterization of olfactomedin related genes with a potential role in pathogenesis of ocular disorders.

Authors:  Arijit Mukhopadhyay; Sangita Talukdar; Ashima Bhattacharjee; Kunal Ray
Journal:  Mol Vis       Date:  2004-04-20       Impact factor: 2.367

Review 10.  Myocilin glaucoma.

Authors:  John H Fingert; Edwin M Stone; Val C Sheffield; Wallace L M Alward
Journal:  Surv Ophthalmol       Date:  2002 Nov-Dec       Impact factor: 6.048

View more
  12 in total

1.  Deletion in the N-terminal half of olfactomedin 1 modifies its interaction with synaptic proteins and causes brain dystrophy and abnormal behavior in mice.

Authors:  Naoki Nakaya; Afia Sultana; Jeeva Munasinghe; Aiwu Cheng; Mark P Mattson; Stanislav I Tomarev
Journal:  Exp Neurol       Date:  2013-10-02       Impact factor: 5.330

2.  Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth.

Authors:  Naoki Nakaya; Afia Sultana; Hee-Sheung Lee; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2012-08-24       Impact factor: 5.157

3.  Deletion of olfactomedin 2 induces changes in the AMPA receptor complex and impairs visual, olfactory, and motor functions in mice.

Authors:  Afia Sultana; Naoki Nakaya; Lijin Dong; Mones Abu-Asab; Haohua Qian; Stanislav I Tomarev
Journal:  Exp Neurol       Date:  2014-09-10       Impact factor: 5.330

4.  Impaired AMPA receptor trafficking by a double knockout of zebrafish olfactomedin1a/b.

Authors:  Naoki Nakaya; Afia Sultana; Stanislav I Tomarev
Journal:  J Neurochem       Date:  2017-11-06       Impact factor: 5.372

5.  Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.

Authors:  Ning Shi; Chen-Xiao Li; Xiao-Bing Cui; Stanislav I Tomarev; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-05       Impact factor: 8.311

6.  Identification and functional characterisation of genetic variants in OLFM2 in children with developmental eye disorders.

Authors:  R Holt; S A Ugur Iseri; A W Wyatt; D A Bax; D Gold Diaz; C Santos; S Broadgate; R Dunn; J Bruty; Y Wallis; D McMullan; C Ogilvie; D Gerrelli; Y Zhang; Nicola Ragge
Journal:  Hum Genet       Date:  2016-11-14       Impact factor: 4.132

7.  Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression.

Authors:  Michelle M Schiro; Sara E Stauber; Tami L Peterson; Chateen Krueger; Steven J Darnell; Kenneth A Satyshur; Norman R Drinkwater; Michael A Newton; F Michael Hoffmann
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

8.  Olfactomedin-1 Has a V-shaped Disulfide-linked Tetrameric Structure.

Authors:  Matti F Pronker; Trusanne G A A Bos; Thomas H Sharp; Dominique M E Thies-Weesie; Bert J C Janssen
Journal:  J Biol Chem       Date:  2015-04-21       Impact factor: 5.157

9.  Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cells.

Authors:  Ning Shi; Xia Guo; Shi-You Chen
Journal:  Mol Biol Cell       Date:  2014-10-08       Impact factor: 4.138

10.  Olfactomedin-like 2 A and B (OLFML2A and OLFML2B) expression profile in primates (human and baboon).

Authors:  Diana Cristina Pérez-Ibave; Rafael González-Alvarez; Margarita de La Luz Martinez-Fierro; Gabriel Ruiz-Ayma; Maricela Luna-Muñoz; Laura Elia Martínez-De-Villarreal; María De Lourdes Garza-Rodríguez; Diana Reséndez-Pérez; Jibran Mohamed-Noriega; Raquel Garza-Guajardo; Víctor Manuel Bautista-De-Lucío; Karim Mohamed-Noriega; Oralia Barboza-Quintana; Carlos Arámburo-De-La-Hoz; Hugo Alberto Barrera-Saldaña; Irám Pablo Rodríguez-Sánchez
Journal:  Biol Res       Date:  2016-11-08       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.